P

Inventor

ROSE-JOHN STEFAN

DE12 patents
⚠️ This page may combine multiple inventors who share the name “ROSE-JOHN STEFAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HADASIT MED RES SERVICE

3 patents
US5919763AJul 6, 1999

IL-6/SIL-6R complex for promotion of liver functions

HADASIT MED RES SERVICE15 citations71
US7897145B2Mar 1, 2011

Methods for the treatment of renal failure

HADASIT MED RES SERVICE0 citations42
US8372389B2Feb 12, 2013

Methods for the treatment of radiation or chemotherapy-induced tissue damage

HADASIT MED RES SERVICE0 citations41

CONARIS RES INST AG

2 patents
US7629147B2Dec 8, 2009

PEGylated soluble GP130-dimers useful as a medicament

CONARIS RES INST AG11 citations79
US7534862B2May 19, 2009

PEGylated soluble gp130-dimers useful as a medicament

CONARIS RES INST AG14 citations79

ANGEWANDTE GENTECHNOLOGIE SYST

1 patent
US7112436B1Sep 26, 2006

Conjugate for modifying interactions between proteins

ANGEWANDTE GENTECHNOLOGIE SYST48 citations88

AKADEMIA MEDYCZNA IM K MARCINK

1 patent
US5935569AAug 10, 1999

Genetic anticancer vaccine

AKADEMIA MEDYCZNA IM K MARCINK4 citations48

BAKER MED RES INST

1 patent
US9765129B2Sep 19, 2017

Treatment of obesity

BAKER MED RES INST0 citations42

APPLIED RESEARCH SYSTEMS

1 patent
US6280975B1Aug 28, 2001

IL-6 mutein and DNA encoding thereto

APPLIED RESEARCH SYSTEMS1 citations39

SEEGERT DIRK

1 patent
US8206948B2Jun 26, 2012

Optimized nucleotide sequences encoding sgp130

SEEGERT DIRK0 citations36

GRÖTZINGER JOACHIM

1 patent
US9187542B2Nov 17, 2015

Ciliary neurotrophic factor variants

GRÖTZINGER JOACHIM0 citations33

GROETZINGER JOACHIM

1 patent
US8501696B2Aug 6, 2013

Soluble GP130 muteins with improved binding activity

GROETZINGER JOACHIM0 citations33